nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—ADRA1A—polycystic ovary syndrome	0.801	1	CbGaD
Tolazoline—Mephentermine—ADRA1A—polycystic ovary syndrome	0.00167	0.278	CrCbGaD
Tolazoline—Naphazoline—ADRA1A—polycystic ovary syndrome	0.00124	0.207	CrCbGaD
Tolazoline—L-Phenylalanine—TH—polycystic ovary syndrome	0.00109	0.182	CrCbGaD
Tolazoline—Dextroamphetamine—ADRA1B—polycystic ovary syndrome	0.000989	0.165	CrCbGaD
Tolazoline—HRH2—adrenal gland—polycystic ovary syndrome	0.000698	0.0776	CbGeAlD
Tolazoline—Dextroamphetamine—ADRA1A—polycystic ovary syndrome	0.000666	0.111	CrCbGaD
Tolazoline—HRH2—endocrine gland—polycystic ovary syndrome	0.000605	0.0673	CbGeAlD
Tolazoline—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.000452	0.0502	CbGeAlD
Tolazoline—ADRA2C—endometrium—polycystic ovary syndrome	0.000403	0.0449	CbGeAlD
Tolazoline—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000381	0.0424	CbGeAlD
Tolazoline—ADRA2C—uterus—polycystic ovary syndrome	0.000372	0.0413	CbGeAlD
Tolazoline—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000365	0.0406	CbGeAlD
Tolazoline—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000364	0.0404	CbGeAlD
Tolazoline—Benzyl alcohol—CYP1A1—polycystic ovary syndrome	0.000343	0.0572	CrCbGaD
Tolazoline—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000342	0.0381	CbGeAlD
Tolazoline—HRH1—endometrium—polycystic ovary syndrome	0.000328	0.0364	CbGeAlD
Tolazoline—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000326	0.0363	CbGeAlD
Tolazoline—ADRA2A—endometrium—polycystic ovary syndrome	0.000322	0.0358	CbGeAlD
Tolazoline—ADRA2C—female gonad—polycystic ovary syndrome	0.000304	0.0338	CbGeAlD
Tolazoline—ADRA2C—vagina—polycystic ovary syndrome	0.000302	0.0336	CbGeAlD
Tolazoline—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000297	0.033	CbGeAlD
Tolazoline—ADRA2A—uterus—polycystic ovary syndrome	0.000297	0.033	CbGeAlD
Tolazoline—HRH1—adipose tissue—polycystic ovary syndrome	0.000295	0.0328	CbGeAlD
Tolazoline—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000291	0.0324	CbGeAlD
Tolazoline—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00029	0.0323	CbGeAlD
Tolazoline—HRH1—adrenal gland—polycystic ovary syndrome	0.000265	0.0295	CbGeAlD
Tolazoline—ADRA2A—adrenal gland—polycystic ovary syndrome	0.00026	0.0289	CbGeAlD
Tolazoline—HRH1—female gonad—polycystic ovary syndrome	0.000247	0.0275	CbGeAlD
Tolazoline—HRH1—vagina—polycystic ovary syndrome	0.000245	0.0273	CbGeAlD
Tolazoline—ADRA2A—female gonad—polycystic ovary syndrome	0.000243	0.027	CbGeAlD
Tolazoline—ADRA2A—vagina—polycystic ovary syndrome	0.000241	0.0268	CbGeAlD
Tolazoline—HRH1—endocrine gland—polycystic ovary syndrome	0.00023	0.0255	CbGeAlD
Tolazoline—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000226	0.0251	CbGeAlD
Tolazoline—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.73e-05	0.000148	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.73e-05	0.000148	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.71e-05	0.000147	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.69e-05	0.000146	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.69e-05	0.000146	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	2.68e-05	0.000145	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.68e-05	0.000145	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.66e-05	0.000144	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.64e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FGF18—polycystic ovary syndrome	2.64e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.64e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.63e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKR1C3—polycystic ovary syndrome	2.62e-05	0.000142	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RBP4—polycystic ovary syndrome	2.62e-05	0.000142	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.62e-05	0.000142	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.62e-05	0.000142	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.59e-05	0.000141	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.58e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP17A1—polycystic ovary syndrome	2.58e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.58e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.57e-05	0.000139	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.57e-05	0.000139	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	2.54e-05	0.000138	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.53e-05	0.000137	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.53e-05	0.000137	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	2.51e-05	0.000136	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	2.5e-05	0.000136	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.49e-05	0.000135	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.49e-05	0.000135	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.48e-05	0.000135	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.48e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.47e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	2.47e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	2.46e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.46e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—YAP1—polycystic ovary syndrome	2.44e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	2.44e-05	0.000132	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.43e-05	0.000132	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GAB1—polycystic ovary syndrome	2.41e-05	0.000131	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.39e-05	0.00013	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.39e-05	0.000129	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	2.37e-05	0.000129	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	2.36e-05	0.000128	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	2.36e-05	0.000128	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.35e-05	0.000128	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.35e-05	0.000127	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.34e-05	0.000127	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.33e-05	0.000127	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.32e-05	0.000126	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.31e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.31e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.31e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.31e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INSR—polycystic ovary syndrome	2.31e-05	0.000125	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.3e-05	0.000125	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.29e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	2.29e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	2.29e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	2.28e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.28e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.26e-05	0.000123	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.25e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	2.25e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	2.24e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—TH—polycystic ovary syndrome	2.23e-05	0.000121	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.22e-05	0.00012	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.19e-05	0.000119	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.18e-05	0.000118	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.18e-05	0.000118	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—LEP—polycystic ovary syndrome	2.17e-05	0.000118	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—SLC2A4—polycystic ovary syndrome	2.17e-05	0.000118	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.16e-05	0.000117	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.15e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.14e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.14e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PGR—polycystic ovary syndrome	2.13e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	2.13e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.13e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.12e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.12e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.11e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	2.09e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.09e-05	0.000114	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	2.05e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.05e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP19A1—polycystic ovary syndrome	2.04e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	2.03e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.03e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.02e-05	0.000109	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.99e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GHRL—polycystic ovary syndrome	1.98e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PLAT—polycystic ovary syndrome	1.98e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.98e-05	0.000107	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.97e-05	0.000107	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.96e-05	0.000106	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.95e-05	0.000106	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.94e-05	0.000105	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.92e-05	0.000104	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.91e-05	0.000104	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.91e-05	0.000104	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	1.9e-05	0.000103	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—VEGFA—polycystic ovary syndrome	1.9e-05	0.000103	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ATF1—polycystic ovary syndrome	1.89e-05	0.000103	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.88e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	1.87e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.87e-05	0.000101	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—POMC—polycystic ovary syndrome	1.87e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.87e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.86e-05	0.000101	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—INS—polycystic ovary syndrome	1.86e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	1.85e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.85e-05	0.0001	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.84e-05	9.97e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	1.82e-05	9.88e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—TH—polycystic ovary syndrome	1.81e-05	9.83e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.8e-05	9.74e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.79e-05	9.73e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.79e-05	9.69e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.78e-05	9.65e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.77e-05	9.59e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.77e-05	9.59e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	1.76e-05	9.56e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.76e-05	9.54e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.75e-05	9.5e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	1.75e-05	9.48e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	1.74e-05	9.42e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	1.74e-05	9.41e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.73e-05	9.41e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.73e-05	9.41e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	1.73e-05	9.4e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	1.73e-05	9.39e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.71e-05	9.25e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.7e-05	9.24e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.69e-05	9.15e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.67e-05	9.07e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.67e-05	9.05e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	1.66e-05	8.99e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.65e-05	8.98e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	1.64e-05	8.92e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.64e-05	8.92e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.64e-05	8.91e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.64e-05	8.88e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.63e-05	8.85e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.61e-05	8.75e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.61e-05	8.74e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.61e-05	8.74e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.61e-05	8.71e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.56e-05	8.44e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.55e-05	8.43e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.55e-05	8.42e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.55e-05	8.39e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	1.54e-05	8.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	1.54e-05	8.37e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.54e-05	8.34e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	1.53e-05	8.32e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.53e-05	8.28e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.52e-05	8.27e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	1.52e-05	8.26e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.52e-05	8.23e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.51e-05	8.21e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.5e-05	8.13e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.49e-05	8.1e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.49e-05	8.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	1.48e-05	8.03e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.46e-05	7.94e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.46e-05	7.91e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.45e-05	7.87e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.44e-05	7.79e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	1.42e-05	7.73e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.42e-05	7.7e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.41e-05	7.65e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	1.41e-05	7.65e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.41e-05	7.63e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.37e-05	7.45e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.36e-05	7.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.36e-05	7.35e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.34e-05	7.25e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.33e-05	7.24e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.33e-05	7.22e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.31e-05	7.08e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.29e-05	7.01e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.28e-05	6.93e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.27e-05	6.88e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.27e-05	6.88e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1.25e-05	6.76e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.25e-05	6.75e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	1.24e-05	6.75e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.24e-05	6.71e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	1.23e-05	6.65e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.22e-05	6.62e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—INS—polycystic ovary syndrome	1.22e-05	6.62e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.19e-05	6.48e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.18e-05	6.39e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.17e-05	6.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.16e-05	6.28e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.14e-05	6.18e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.1e-05	5.96e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	1.09e-05	5.92e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.09e-05	5.9e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.07e-05	5.78e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	1.06e-05	5.78e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	1.06e-05	5.77e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.06e-05	5.73e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.06e-05	5.72e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.04e-05	5.66e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	1.03e-05	5.56e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	1.02e-05	5.53e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	1.01e-05	5.48e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1e-05	5.44e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	9.96e-06	5.4e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	9.91e-06	5.37e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—INS—polycystic ovary syndrome	9.91e-06	5.37e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	9.86e-06	5.35e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	9.86e-06	5.35e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	9.7e-06	5.26e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.49e-06	5.15e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.37e-06	5.08e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	9.31e-06	5.05e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	9.14e-06	4.96e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	9.09e-06	4.93e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	8.97e-06	4.86e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	8.92e-06	4.84e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.79e-06	4.77e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.78e-06	4.76e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	8.65e-06	4.69e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	8.62e-06	4.68e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	8.62e-06	4.67e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.35e-06	4.53e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	8.33e-06	4.52e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	8.28e-06	4.49e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.19e-06	4.44e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—polycystic ovary syndrome	8.11e-06	4.4e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	8.08e-06	4.38e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	8.01e-06	4.35e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	8.01e-06	4.34e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.61e-06	4.13e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	7.54e-06	4.09e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.9e-06	3.74e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.72e-06	3.65e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	6.59e-06	3.58e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.44e-06	3.5e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	6.13e-06	3.32e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.74e-06	3.11e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.63e-06	3.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.23e-06	2.84e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	4.77e-06	2.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	4.46e-06	2.42e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	3.97e-06	2.15e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.9e-06	2.11e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	3.62e-06	1.96e-05	CbGpPWpGaD
